Psoriasis Clinical Trials in New York

Showing 161-180 of 183 trials

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

NCT01855880

This is a Phase IIa, randomised, double-blind, placebo-controlled, multiple dose, multi-center study of AbGn-168H in subjects with moderate to severe chronic plaque psoriasis.The objectives of this study is to investigate efficacy, safety, tolerability, and pharmacokinetics (PK) of multiple doses of AbGn-168H administered intravenously to patients with moderate to severe chronic plaque psoriasis.

Moderate to Severe Chronic Plaque Psoriasis

AbGenomics B.V Taiwan Branch54 participantsStarted May 2013

Little Rock, Arkansas, United States • Rogers, Arkansas, United States • Boynton Beach, Florida, United States +12 more locations

COMPLETED< 1 mile

An Exploratory Genetic Study in Participants With Psoriasis

NCT02155192

The purpose of this study is to evaluate the association between genetic factors and response to treatment (guselkumab, ustekinumab, adalimumab, or etanercept) and psoriasis (scaly skin rash).

Psoriasis

Janssen Research & Development, LLC712 participantsStarted Mar 2014

Bakersfield, California, United States • Los Angeles, California, United States • Ocala, Florida, United States +16 more locations

Phase IIa Study of Multiple Doses of AbGn-168H by iv Infusion in Moderate to Severe Chronic Plaque Psoriasis Patients

An Exploratory Genetic Study in Participants With Psoriasis

Psoriasis Trials in Other Cities

Cell Responses to IFN-gamma

A Study Comparing the Safety and Efficacy of Two Dosing Regimens of ABT-874 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Continuation Study in Moderate to Severe Psoriasis

Effectiveness and Safety of 3 Dosing Regimens of CP-690,550 to Placebo in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Narrowband UVB Light Therapy to Patients With Dark Skin Types Who Have 10% of Their Body Involved With Psoriasis Vulgaris.

Randomized Study of PH-10 for Psoriasis

Study to Assess VB-201 in Patients With Psoriasis

Low-Dose (17.5 mg/Day) Acitretin: Comparable Efficacy Without the Side Effects?

Efficacy and Safety of Adalimumab in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Open Label Study of Adalimumab in Subjects Who Have a Sub-optimal Response to Systemic Therapy or Phototherapy

To Study the Effects of CD25 and Low Dose Cyclosporin in the Treatment of Active Psoriasis Vulgaris

Etanercept With Tacrolimus for Psoriasis

A Study for Adults With Plaque Psoriasis

Safety and Efficacy of Abatacept Versus Placebo in Participants With Psoriatic Arthritis

Impact of the Severity of Pediatric Psoriasis on Childhood Body Mass Index

Study to Evaluate Apo805K1 in Subjects With Moderate to Severe Chronic Plaque Psoriasis

Prevalence of Psoriatic Arthritis in Adults With Psoriasis: An Estimate From Dermatology Practice

Evaluation of the Efficacy, Safety and Toleration of CT327 Ointment in Patients With Psoriasis Vulgaris

Other Conditions in New York